Fingerprint
Dive into the research topics of 'Long-term patient-reported outcomes from an open-label safety and efficacy study of bosutinib in Philadelphia chromosome–positive chronic myeloid leukemia patients resistant or intolerant to prior therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically